A COMPARISON OF HTA RECOMMENDATIONS ISSUED BY AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT (AHTAPOL) IN POLAND AND THE SCOTTISH MEDICINES CONSORTIUM (SMC)

被引：0
|
作者：
Kolasa, K. [1 ]
机构：
[1] AstraZeneca, Sodertalje, Sweden
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)74223-6
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A250 / A250
页数：1
相关论文
共 50 条
  • [31] THE INFLUENCE OF SAFETY ISSUES ON DECISIONS OF CONSULTATIVE COUNCIL OF THE AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT IN POLAND
    Farkowski, M. M.
    Baran, J.
    Matusewicz, W.
    VALUE IN HEALTH, 2010, 13 (03) : A98 - A98
  • [32] A SCOPING REVIEW OF HEALTH TECHNOLOGY ASSESSMENT AGENCY (HTA) AND HEALTH ECONOMIC (HE) MODELLING GUIDELINES FOR IDENTIFICATION OF HEALTH ECONOMIC MODEL INPUTS
    Lister, J.
    Paisley, S.
    Tappenden, P.
    Carroll, C.
    VALUE IN HEALTH, 2023, 26 (12) : S375 - S375
  • [33] European Medicines Agency-Health Technology Assessment Parallel Consultation Platform: An Industry Perspective
    Khan, Saima
    Carter, Monique
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (04) : 822 - 825
  • [34] The transparency of published health technology assessment-based recommendations on pharmaceutical reimbursement in Poland
    Bochenek, Tomasz
    Kocot, Ewa
    Rodzinka, Marcin
    Godman, Brian
    Maciejewska, Katarzyna
    Kamal, Susan
    Pilc, Andrzej
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2017, 17 (04) : 385 - 400
  • [35] Improving the Contribution of Regulatory Assessment Reports to Health Technology Assessments-A Collaboration between the European Medicines Agency and the European network for Health Technology Assessment
    Berntgen, Michael
    Gourvil, Anne
    Pavlovic, Mira
    Goettsch, Wim
    Eichler, Hans-Georg
    Kristensen, Finn Borlum
    VALUE IN HEALTH, 2014, 17 (05) : 634 - 641
  • [36] From recommendation to action: psychosocial factors influencing physician intention to use Health Technology Assessment (HTA) recommendations
    Gagnon, Marie-Pierre
    Sanchez, Emilia
    Pons, Joan M. V.
    IMPLEMENTATION SCIENCE, 2006, 1 (1)
  • [37] From recommendation to action: psychosocial factors influencing physician intention to use Health Technology Assessment (HTA) recommendations
    Marie-Pierre Gagnon
    Emília Sánchez
    Joan MV Pons
    Implementation Science, 1
  • [38] ADVANCING EVIDENCE TO ACTION: A COMPARISON OF HEALTH TECHNOLOGY ASSESSMENT (HTA) OUTCOMES IN ENGLAND, FRANCE AND GERMANY
    Schaefer, R.
    Hernandez, D.
    Schlander, M.
    VALUE IN HEALTH, 2020, 23 : S70 - S70
  • [39] Health technology assessment (HTA) in England, France and Germany: What do matched drug pairs tell us about recommendations by national HTA agencies?
    Schaefer, Ramon
    Hernandez, Diego
    Selberg, Lorenz
    Schlander, Michael
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (16) : 1187 - 1196
  • [40] COMPARING NON-ONCOLOGICAL RARE CONDITION SUBMISSIONS TO THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) VERSUS SCOTTISH MEDICINES CONSORTIUM (SMC) FROM 2001 TO 2021
    White, A.
    Wong, R.
    Guest, S.
    Carroll, C.
    Essat, M.
    Rowen, D.
    Young, V. J.
    Brazier, J. E.
    VALUE IN HEALTH, 2022, 25 (12) : S326 - S327
12345